- Home
- PRE vs ARMP Comparison
PRE vs ARMP Comparison
Compare PRE & ARMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRE
- ARMP
- Stock Information
- Founded
- PRE 2014
- ARMP N/A
- Country
- PRE Hong Kong
- ARMP United States
- Employees
- PRE N/A
- ARMP N/A
- Industry
- PRE Biotechnology: Laboratory Analytical Instruments
- ARMP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PRE Industrials
- ARMP Health Care
- Exchange
- PRE Nasdaq
- ARMP Nasdaq
- Market Cap
- PRE 52.5M
- ARMP 52.1M
- IPO Year
- PRE N/A
- ARMP N/A
- Fundamental
- Price
- PRE $5.19
- ARMP $1.36
- Analyst Decision
- PRE Buy
- ARMP Strong Buy
- Analyst Count
- PRE 1
- ARMP 1
- Target Price
- PRE $9.00
- ARMP $7.00
- AVG Volume (30 Days)
- PRE 10.6K
- ARMP 15.0K
- Earning Date
- PRE 06-17-2025
- ARMP 05-20-2025
- Dividend Yield
- PRE N/A
- ARMP N/A
- EPS Growth
- PRE N/A
- ARMP N/A
- EPS
- PRE N/A
- ARMP N/A
- Revenue
- PRE $30,621,000.00
- ARMP $5,174,000.00
- Revenue This Year
- PRE $148.70
- ARMP $8.43
- Revenue Next Year
- PRE $82.89
- ARMP N/A
- P/E Ratio
- PRE N/A
- ARMP N/A
- Revenue Growth
- PRE 40.83
- ARMP 14.24
- 52 Week Low
- PRE $3.10
- ARMP $0.90
- 52 Week High
- PRE $6.99
- ARMP $3.45
- Technical
- Relative Strength Index (RSI)
- PRE 65.84
- ARMP 47.08
- Support Level
- PRE $5.07
- ARMP $1.29
- Resistance Level
- PRE $5.40
- ARMP $1.70
- Average True Range (ATR)
- PRE 0.34
- ARMP 0.17
- MACD
- PRE 0.06
- ARMP 0.02
- Stochastic Oscillator
- PRE 75.91
- ARMP 34.62
About PRE Prenetics Global Limited
Prenetics Global Ltd is a health sciences company dedicated to consumer and clinical health. Its consumer initiative is led by IM8, a new health and wellness brand, and Europa, a U.S. sports distribution company. The clinical division is led by Insighta, focused on multi-cancer early detection technologies. This is followed by ACT Genomics, which has achieved FDA clearance for genomic profiling of solid tumors, and CircleDNA, which uses NGS to offer DNA tests. Each Prenetics unit impacts health by 'enhancing life through science'.
About ARMP Armata Pharmaceuticals Inc.
Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.